NCT06810908

Brief Summary

INTRODUCTION Humeral shaft fractures can be treated either nonsurgically or surgically with good and comparable outcomes at one year. However, up to 30% of nonsurgically treated patients have problems with the fracture healing leading to later surgery. The functional outcomes in these patients undergoing later surgery are inferior to those who heal uneventfully with the primary treatment. Although surgically treated patients have significantly less problems with fracture union compared with nonsurgically treated patients, they have elevated risk for infection and iatrogenic radial nerve palsy. The reported infection risk with plate osteosynthesis is around 3%, and with intramedullary nailing around 1.5%. The risk of radial nerve injury during surgery is 4%. Current literature regarding risk factors for treatment failure in the patients with humeral shaft fractures is controversial and scarce especially in surgically treated patients. This study aims to identify the risk factors for treatment failure both in nonsurgically and surgically treated patients in the largest cohort of humeral shaft fracture patients to date. MATERIALS AND METHODS This retrospective study is conducted in Helsinki and Tampere University hospitals. Hospital registry is used to identify adult patients with humeral shaft fractures treated in the units. For the Helsinki University hospital, the included patients were treated between 2006 and 2016, and for the Tampere University hospital between 2001 and 2022. Separate analysis of the risk factors for treatment failure in nonsurgically and surgically treated patients will be carried out. The definition of treatment failure for nonsurgically treated patients will be a need of later surgery due to fracture healing problems and for surgically treated patients, a secondary surgery due to treatment failure. A secondary analysis will assess the risk factors for later surgery due to fracture nonunion both in nonsurgically and surgically treated patients. Additionally, risk factors for other unfavorable outcomes such as wound infections and secondary radial nerve palsy will be explored if deemed statistically feasible. The data include following variables:

  • Patent-related variables
  • Age at the time of trauma
  • Gender
  • Underlying comorbidies
  • ASA classification
  • Overweight
  • Smoking
  • Alcohol consumption
  • Under the influence of alcohol upon arrival
  • Use of other substances
  • Injury-related variables
  • AO type and group
  • Fracture site (proximal, mid, distal)
  • Open fracture (Gustilo-Andersson classification)
  • Periprosthetic fracture
  • Additional injuries
  • Trauma energy (low or high)
  • Treatment-related variables
  • Primary treatment
  • Treatment changes
  • Fracture nonunion/union with the primary treatment STATISTICAL ANALYSIS PLAN The statistical analysis is based on predictive approach following guidelines from Harrell et al. and Heinze et al. Logistic regression will be used since the outcome is binary in all models. Baseline variables included in the predictive analysis: age, gender, comorbidities, ASA classification, BMI, smoking, alcohol consumption/under influence upon arrival, AO type, fracture site, trauma energy. All baseline variables will be added simultaneously to the logistic model. Variable missingness is assessed and Missing Completely at Random (MCAR) will be assumed for any missing data and multiple imputation is used. Imputation is done if missingness is less than 20%. Variables with higher than 20% missingness are excluded from primary analyses but included in the secondary analyses. For each the overall pseudo-R2 is estimated and used to interpret the applicability of baseline predictors. Variable importance is also assessed using Wald chi-squared test minus degrees of freedom. Calibration plots will be printed for all three models. Multiplicity is not considered since the study is not focused on single regression coefficients. Specific multiple testing will not be used. When appropriate, 95% confidence intervals will be calculated, and associated p-values calculated. Analysis is done with RStudio using rms package.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2001

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2001

Completed
22 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

January 24, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 6, 2025

Completed
Last Updated

February 6, 2025

Status Verified

February 1, 2025

Enrollment Period

22 years

First QC Date

January 24, 2025

Last Update Submit

February 1, 2025

Conditions

Keywords

Humeral shaft fractureRisk factors for treatment failure

Outcome Measures

Primary Outcomes (1)

  • The risk factors for treatment failure

    The definition of treatment failure for nonsurgically treated patients will be a need of later surgery due to fracture healing problems and for surgically treated patients, a secondary surgery due to treatment failure.

    Minimum of 1 year

Study Arms (1)

Adult patient with humeral shaft fracture

Procedure: Internal fixation or bracing

Interventions

Adult patients with humeral shaft fractures have been treated either with internal fixation or functional bracing according to the discretion of the treating surgeon.

Adult patient with humeral shaft fracture

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients with humeral shaft fracture treated in Helsinki (2006-2016) or Tampere (2001-2022) University Hospitals.

You may qualify if:

  • Humeral shaft fracture
  • years or older
  • Treated in Helsinki or Tampere University hospital
  • Treatment outcome known (from x-ray and/or patient records)

You may not qualify if:

  • Treatment outcome not known

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Fracture Fixation, InternalBraces

Intervention Hierarchy (Ancestors)

Fracture FixationOrthopedic ProceduresTherapeuticsSurgical Procedures, OperativeOrthotic DevicesOrthopedic EquipmentSurgical EquipmentEquipment and Supplies

Study Officials

  • Lasse Rämö, MD, PhD

    Helsinki University Central Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Orthopaedic surgeon, MD, PhD

Study Record Dates

First Submitted

January 24, 2025

First Posted

February 6, 2025

Study Start

January 1, 2001

Primary Completion

December 31, 2022

Study Completion

December 31, 2024

Last Updated

February 6, 2025

Record last verified: 2025-02